Capital expenditure · 2013–2025

Akebia Therapeutics capital expenditure

$291,000+781.8% · FY2025

Akebia Therapeutics (AKBA) reported $291,000 in capital expenditure for fiscal 2025, +781.8% year on year.

$19,0002013$229,0002014$414,0002015$2.7M2016$1.6M2017$1.6M2018$6.7M2019$317,0002020$59,0002021$114,0002022$02023$33,0002024$291,0002025
Akebia Therapeutics — Capital expenditure, 2013–2025
Fiscal yearCapital expenditureChangeFiling
FY20252025-12-31$291,000+781.8%Open →
FY20242024-12-31$33,000+$33,000Open →
FY20232023-12-31$0−100.0%Open →
FY20222022-12-31$114,000+93.2%Open →
FY20212021-12-31$59,000−81.4%Open →
FY20202020-12-31$317,000−95.2%Open →
FY20192019-12-31$6.7M+314.4%Open →
FY20182018-12-31$1.6M−1.0%Open →
FY20172017-12-31$1.6M−39.1%Open →
FY20162016-12-31$2.7M+543.0%Open →
FY20152015-12-31$414,000+80.8%Open →
FY20142014-12-31$229,000+1,105.3%Open →
FY20132013-12-31$19,000—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +25.5%

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Akebia Therapeutics capital expenditure |url=https://companiesranked.com/en/company/akebia-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Akebia Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/capital-expenditure

BibTeX

@misc{companiesranked-en-company-akebia-therapeutics-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Akebia Therapeutics capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001517022-26-000020 · February 26, 2026

{{cite web |title=Akebia Therapeutics capital expenditure — 10-K (0001517022-26-000020) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000020/akba-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Akebia Therapeutics overview